Why the study?
Ventricular abnormal potentials identification is challenging, yet they constitute key ablation targets during substrate-guided mapping and ablation for ventricular tachycardia.
Key points are not available for this paper at this time.
Ventricular abnormal potentials (VAPs) identification is a challenging issue, since they constitute the ablation targets in substrate-guided mapping and ablation procedures for ventricular tachycardia (VT) treatment.
No takes yet. Share an insight, caveat, or question.
Baldazzi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: